Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In Alzheimer's disease, neurofibrillary degeneration results from the aggregation of abnormally phosphorylated Tau proteins into filaments and it may be related to the reactivation of mitotic mechanisms. In order to investigate the link between Tau phosphorylation and mitosis, Xenopus laevis oocytes in which most of the M‐phase regulators have been discovered were used as a cell model. The human Tau isoform htau412 (2+3–10+) was microinjected into prophase I oocytes that were then stimulated by progesterone that activate cyclin‐dependent kinase pathways. Hyperphosphorylation of the Tau isoform, which is characterized by a decrease of its electrophoretic mobility and its labelling by a number of phosphorylation‐dependent antibodies, was observed at the time of germinal vesicle breakdown. Surprisingly, Tau immunoreactivity, considered as typical of Alzheimer's pathology (AT100 and phospho‐Ser422), was observed in meiosis II. Because meiosis II is considered as a mitosis‐like phase, we investigated if our observation was also relevant to a neurone‐like model. Abnormal Tau phosphorylation was detected in mitotic human neuroblastoma SY5Y cells overexpressing Tau. Regarding AT100‐immunoreactivity and phospho‐Ser422, we suggest that phosphatase 2A inhibition and a phosphorylation combination of mitotic kinases may lead to this Alzheimer‐type phosphorylation. Our results not only demonstrate the involvement of mitotic kinases in Alzheimer‐type Tau phosphorylation but also indicate that Xenopus oocyte could be a useful model to identify the kinases involved in this process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P. (1999) · Nature · doi:10.1038/21650 · Cited by 721
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., & Cras, P. (1994) · Biochemical Journal · doi:10.1042/bj3010871 · Cited by 375 · cited 1×
“Phosphorylation-dependent monoclonal antibodies included AD2 directed against phosphorylated Ser396–404 (Buée-Scherrer et al. 1996), AT180 labelling phosphorylated Thr231, AT270 recognizing phosphorylated Thr181, AT8 directed against phosphorylated Ser202/Thr205 (Goedert et al. 1994, 1995) Fig.”
Background
Cited by
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758
“These cybrid lines also exhibit altered calcium homeostasis, mitochondrial membrane potential depolarization, abnormal mitochondrial morphology, molecular stress response pathway activation, increased activation and expression of apoptotic proteins, and excessive protein aggregation (including Ab in AD cybrids and a-s…”
BackgroundTau phosphorylation: physiological and pathological consequences
Stoothoff, W. H., & Johnson, G. V. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 442
Microtubule-associated protein tau in development, degeneration and protection of neurons
Wang, J.-Z., & Liu, F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.002 · Cited by 398
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252
Metadata
- Authors
- Delobel, P., Flament, S., Hamdane, M., Mailliot, C., Sambo, A., Bégard, S., Sergeant, N., Delacourte, A., Vilain, J., & Buée, L.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2002-10
- Volume
- 83
- Issue
- 2
- Pages
- 412-420
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1539836937
- Cited by
- 72
- References
- 3
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis. https://app.cochat.ai/papers/10.1046/j.1471-4159.2002.01143.x
- The paper
- Delobel, P., Flament, S., Hamdane, M., Mailliot, C., Sambo, A., Bégard, S., Sergeant, N., Delacourte, A., Vilain, J., & Buée, L. (2002). Abnormal Tau phosphorylation of the Alzheimer‐type also occurs during mitosis. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2002.01143.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.